Aquila Bioscience is based in the heart of the medical device technology sector in Galway Ireland.
Aquila was founded in 2012 at the National University of Ireland, Galway, by Lokesh Joshi, Stokes Professor of Glycoscience. We have developed revolutionary decontamination technology in collaboration with the Czech University of Defence and Defence Forces Ireland, that protects against harmful pathogens and other viral infections like coronavirus.
We have successfully applied this technology and launched the first Aquila Bioscience product, “ABD Device”. It is free from alcohol and toxic chemicals, and is a biodegradable Class I device that safely captures, removes and neutralizes harmful pathogens and viral infections like coronavirus from the skin and surfaces.
Our experienced R&D team bring together a range of science disciplines, bridging Glycobiology, Immunology, Microbiology, biochemistry and analytical chemistry.
Using nature’s solutions to develop technologically-advanced and environmentally-friendly products to improve the world’s health
Prof. Lokesh Joshi – Founder
Dr. Marta Utratna – R&D
Dr. Anup Mammen – R&D
Dr Ciarán Duffy – Research and Innovation Funding
Cormac Lynch – CEO
Fran O’Flaherty – Commercialisation
Lorraine Eagleton – Sales & Marketing
Sean Mannion – Manufacturing
John Martyn – Regulatory
Niall Mooney – Finance
Gillian Knight – Human Resources